Barcelona, Spain

Nuria Valls Vidal



 

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Nuria Valls Vidal

Introduction

Nuria Valls Vidal is an accomplished inventor based in Barcelona, Spain, with a remarkable portfolio of eight patents. Her work primarily focuses on innovative compounds that have significant implications in the medical field, particularly in the treatment of various diseases.

Latest Patents

Among her latest contributions to science are several groundbreaking patents regarding (hetero)aryl cyclopropylamine compounds, which serve as LSD1 inhibitors. These inventions detail the compounds of formula I and their potential use in therapies aimed at treating or preventing conditions such as cancer, neurological diseases, and viral infections. The patented compounds signify a promising advancement in therapeutic options for various critical health issues.

Career Highlights

Nuria Valls Vidal currently works at Oryzon Genomics S.A., a company renowned for its research and development in innovative genomic solutions. Her role at the company allows her to contribute significantly to the field of genomics, enhancing our understanding and treatment of complex diseases through innovative therapies.

Collaborations

Throughout her career, Nuria has collaborated with notable coworkers such as Matthew Colin Thor Fyfe and Alberto Ortega Muñoz. These collaborations bring together diverse expertise, fostering innovative approaches to drug discovery and development.

Conclusion

Nuria Valls Vidal stands out as a pivotal figure in the field of innovation, particularly through her patented inventions that hold the promise of revolutionizing treatments for serious health conditions. Her dedication to advancing medical science is reflected in her work at Oryzon Genomics and her collaborative efforts with her peers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…